SBIR/STTR Research Award

A BREATH TEST TO DETECT BACTERIAL OVERGROWTH IN ELDERLY

Award identifier 2dfb62d0db79fe690529bf3bd8350aa28376d4083ff3f305968841b73f04be14Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$830,682

Program and phase

SBIR · Phase II

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
METABOLIC SOLUTIONS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Bacterial overgrowth is a condition found primarily in the elderly and is estimated to affect 33% of people over 65 years. It causes great discomfort and clinically important nutritional deficiencies if left untreated. The underlying cause is reduced gastric acid secretion associated with aging. Management of overgrowth is hampered because low cost and easy to use diagnostic tests do not exist. Detection is meaningful because while the condition is never cured it can be effectively controlled through treatment. Our objective is to develop an easy to use and cost effective test to detect bacterial overgrowth. The clinical utility is the ability to detect the bacteria overgrowth as accurately as the gold standard (jejunal cultures) in patients exhibiting classic disease symptoms but whom ordinarily wouldn't receive expensive and invasive jejunal culture. The test will accurately detect the condition pre- and post-therapy and lead to quality of life improvement. The novelty of this proposal is the use of a non-invasive breath test employing a naturally occurring sugar labeled with carbon-13 as a probe. If overgrowth is present, the bacteria is present, the bacteria in the small intestine metabolize the labeled substrate and high concentrations of (13)CO(2) are expired in the breath. PROPOSED COMMERCIAL APPLICATION: There are 25 million Americans over the age of 65 and they accounted for 10 million physician office visits with complaints of classic overgrowth symptoms The proposed test will significantly reduce national health care expenditures because proper diagnosis will lead to fewer office visits, more prudent use of drugs and better general health and well-being in the elderly.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.